期刊
BRITISH JOURNAL OF PHARMACOLOGY
卷 138, 期 7, 页码 1207-1209出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjp.0705185
关键词
alpha-amyloid; neurotoxicity; adenosine; caffeine; A(2A) receptors; neuroprotection
Adenosine is a neuromodulator in the nervous system and it has recently been observed that pharmacological blockade or gene disruption of adenosine A(2A) receptors confers neuroprotection under different neurotoxic situations in the brain. We now observed that coapplication of either caffeine (1-25 mum) or the selective A(2A) receptor antagonist, 4-(2-[7-amino-2(2-furyl)(1,2,4)triazolo (2,3-a)(1,3,5)triazin-5-ylamino]ethyl)phenol (ZM 241385, 50 nm), but not the A receptor antagonist, 8-cyclopentyltheophylline (200 nm), prevented the neuronal cell death caused by exposure of rat cultured cerebellar granule neurons to fragment 25 - 35 of beta-amyloid protein (25 mum for 48 h), that by itself caused a near three-fold increase of propidium iodide-labeled cells. This constitutes the first in vitro evidence to suggest that adenosine A(2A) receptors may be the molecular target responsible for the observed beneficial effects of caffeine consumption in the development of Alzheimer's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据